Literature DB >> 8837578

Risks and benefits of combined maze procedure for atrial fibrillation associated with organic heart disease.

A T Kawaguchi1, Y Kosakai, Y Sasako, K Eishi, K Nakano, Y Kawashima.   

Abstract

OBJECTIVES: This study sought to identify the risks and benefits of adding the maze procedure in patients with atrial fibrillation (AF) undergoing operation for underlying organic cardiac disorders.
BACKGROUND: Persistent AF often leaves patients symptomatic even after otherwise successful cardiac surgery.
METHODS: Fifty-one patients undergoing valvular operation and the maze procedure (n = 43) or repair of congenital anomalies (n = 8) combined with the maze procedure were compared with 51 patients (control group) matched for underlying diseases and procedures except for the maze operation. Each group, including 31 patients with a concomitant tricuspid annuloplasty and 12 undergoing reoperation, were similar in age, duration of arrhythmia, degree of cardiomegaly and New York Heart Association functional class.
RESULTS: Patients undergoing the maze procedure had longer cardiopulmonary bypass time (213 vs. 144 min, p < 0.0001), longer cardiac arrest (134 vs. 93 min, p < 0.0001) and greater blood loss with longer respiratory care (39 vs. 18 h p = 0.021) and intensive care unit stay but no mortality. No significant differences were found in catecholamine or transfusion requirements immediately after operation. Sustained AF was much less frequent in the maze group (12% at 1 year) than the control group (86%, p < 0.0001), with an average follow-up period of 32 months (range 25 to 42). Atrial contraction was documented in 41 (80%) and 40 (78%) patients for right and left ventricular filling, respectively, after the maze procedure, resulting in a significantly smaller cardiac size and improved functional capacity. Medication was discontinued in seven patients in the maze group compared with two in the control group.
CONCLUSIONS: Improved restoration of atrial rhythm and contraction with combined maze operation appeared to justify the increased operative time and complexity and postoperative care.

Entities:  

Mesh:

Year:  1996        PMID: 8837578     DOI: 10.1016/s0735-1097(96)00275-6

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  11 in total

Review 1.  [Cardiology update. I: Electrophysiology].

Authors:  P Weismüller; H J Trappe
Journal:  Med Klin (Munich)       Date:  1999-01-15

Review 2.  Surgery for atrial fibrillation.

Authors:  J M McComb
Journal:  J Thromb Thrombolysis       Date:  1999-01       Impact factor: 2.300

3.  Assessment of concomitant paroxysmal atrial fibrillation ablation in mitral valve surgery patients based on continuous monitoring: does a different lesion set matter?

Authors:  Alexandr Bogachev-Prokophiev; Sergey Zheleznev; Alexey Pivkin; Evgeny Pokushalov; Alexander Romanov; Vladimir Nazarov; Alexander Karaskov
Journal:  Interact Cardiovasc Thorac Surg       Date:  2013-11-19

4.  Modified radial v/s biatrial maze for atrial fibrillation in rheumatic valvular heart surgery.

Authors:  Sajid A Sayed; Ashish Katewa; Vivek Srivastava; Sujit Jana; Anil M Patwardhan
Journal:  Indian Heart J       Date:  2014-06-06

Review 5.  Catheter-ablative techniques for the treatment of atrial fibrillation.

Authors:  P G Guerra; M D Lesh
Journal:  Curr Cardiol Rep       Date:  1999-07       Impact factor: 2.931

Review 6.  Novel approaches for the surgical treatment of atrial fibrillation: time for a guideline revision?

Authors:  Carlo Nicola De Cecco; Vitaliano Buffa; Vincenzo David; Stefano Fedeli
Journal:  Vasc Health Risk Manag       Date:  2010-08-09

7.  Mechanism of improvement in exercise capacity after the maze procedure combined with mitral valve surgery.

Authors:  S Yuda; S Nakatani; Y Kosakai; T Satoh; Y Goto; M Yamagishi; K Bando; S Kitamura; K Miyatake
Journal:  Heart       Date:  2004-01       Impact factor: 5.994

Review 8.  Visualization of catheter ablation for atrial fibrillation: Impact of devices and anatomy.

Authors:  Mark A Benscoter; Paul A Iaizzo
Journal:  World J Cardiol       Date:  2015-11-26

Review 9.  Management of atrial fibrillation.

Authors:  Puneet Kakar; Christopher J Boos; Gregory Y H Lip
Journal:  Vasc Health Risk Manag       Date:  2007

10.  Surgical Treatment of Concomitant Atrial Fibrillation: Focus onto Atrial Contractility.

Authors:  Claudia Loardi; Francesco Alamanni; Claudia Galli; Moreno Naliato; Fabrizio Veglia; Marco Zanobini; Mauro Pepi
Journal:  Biomed Res Int       Date:  2015-07-01       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.